Abstract
The active rational medical prophylaxis of pulmonary embolism by the use of heparin has been discouraged because of the involved technical procedures required for maintaining continuous anticoagulant effects. Although recent reports on the routine use of dicumarol have been promising,1the potential hazards, the unpredictable treatment failures and the requisite complicated laboratory controls do not make this drug the anticoagulant of choice.2The therapeutic attack up to the present has been based, for the most part, on the surgical interruption of the continuity of the clot-bearing vein or veins. Our purpose in this communication is to propose a safe, rational method of heparinization for the conservative treatment of thromboembolic disease which obviates previous objections to the use of this drug. Recognition of the increasing incidence of venous thrombosis in the calf of the leg and in the plantar area has stimulated renewed interest in the problem of intravascular
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
